Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Glaxo Said to Be Among Three Bidders for Turkey’s Biofarma
Bloomberg
Thu, 04/7/11 - 05:17 pm
GSK
M&A
Turkey
Biofarma
Alcon shareholders approve sale to Novartis
Yahoo/AP
Thu, 04/7/11 - 05:16 pm
Alcon
Novartis
M&A
Analyst: J&J may need a $10B-plus deal
Fierce Pharma
Thu, 04/7/11 - 01:41 pm
JNJ
M&A
Valeant CEO Spurns Drug Research for Deals With Cephalon Fight
Bloomberg
Thu, 04/7/11 - 09:17 am
Vertex Pharmaceuticals
R&D
M&A
Cephalon
Pharma CEOs
J. Michael Pearson
Cancer drug companies SuperGen, Astex to merge in cash, stock deal
Bizjournals.com
Thu, 04/7/11 - 09:15 am
M&A
Astex
Supergen
Bankers expect more Japanese-led M&A in pharma
Fierce Pharma
Tue, 04/5/11 - 09:58 pm
M&A
Japan
Cephelon rejects Valeant takeover offer
Marketwatch
Tue, 04/5/11 - 09:11 pm
hostile bid
Valeant Pharmaceuticals
M&A
Cephalon
Merck to acquire Inspire Pharma for $430 million
Reuters
Tue, 04/5/11 - 10:28 am
Inspire
Merck
M&A
Forest Labs. Extends Tender Offer To Buy Clinical Data Inc.
RTT News
Mon, 04/4/11 - 09:14 am
M&A
Clinical Data
Forest Labs
KKR Agrees To Buy Pfizer's Capsugel Unit; FDA Deems Application Incomplete
WSJ Online
Mon, 04/4/11 - 08:49 am
FDA
M&A
Pfizer
Capsugel
KKR
Actelion board nominees deny sale is main aim
Reuters
Mon, 04/4/11 - 08:45 am
M&A
Actelion
Fund sues Cephalon as Valeant hints at higher bid
Fierce Pharma
Fri, 04/1/11 - 11:20 am
Cephalon
Valeant Pharmaceuticals
M&A
Valeant's Surprise Bid for Cephalon: Repeating a Growth Trick?
Seeking Alpha
Thu, 03/31/11 - 11:56 am
M&A
Cephalon
Valeant Pharmaceuticals
Valeant may up Cephalon offer if given books
Winnipeg Free Press, Canada
Thu, 03/31/11 - 10:45 am
Cephalon
Valeant Pharmaceuticals
M&A
Cephalon’s Shares Surge Above Offer Price
NY Times, NY
Wed, 03/30/11 - 12:42 pm
M&A
Cephalon
Valeant Pharmaceuticals
Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom
In-Pharm
Wed, 03/30/11 - 11:41 am
Roche
M&A
Novartis
Cephalon Stock Rises Above Valeant Takeover Bid of $73 a Share
Bloomberg
Wed, 03/30/11 - 11:39 am
M&A
Valeant Pharmaceuticals
Cephalon
Cephalon continues buyout spree with $163M ChemGenex deal
Fierce Biotech
Tue, 03/29/11 - 11:46 am
Cephalon
ChemGenex
M&A
Roche will not be for sale, vice chmn tells paper
Reuters
Mon, 03/28/11 - 11:43 am
Roche
M&A
CPEX shareholders vote for sale
Yahoo/AP
Thu, 03/24/11 - 03:17 pm
CPEX Pharmaceuticals
M&A
Pages
« first
‹ previous
…
279
280
281
282
283
284
285
286
287
…
next ›
last »